These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 12206338
1. Optimal age for measles vaccination. Vidyashankar C. J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338 [Abstract] [Full Text] [Related]
2. Seroconversion after measles vaccination at nine and fifteen months of age. Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S. Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768 [Abstract] [Full Text] [Related]
3. Measles antibody in the children in Ubon Ratchathani province. Saipan P, Jiwapaisarnpong T, Pattanadilok S, Loyha Y, Janggajit T. J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960 [Abstract] [Full Text] [Related]
4. An evaluation of measles revaccination among school-entry-aged children. Watson JC, Pearson JA, Markowitz LE, Baughman AL, Erdman DD, Bellini WJ, Baron RC, Fleming DW. Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596 [Abstract] [Full Text] [Related]
5. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Nkrumah FK, Osei-Kwasi M, Dunyo SK, Koram KA, Afari EA. Bull World Health Organ; 1998 May; 76(4):353-9. PubMed ID: 9803586 [Abstract] [Full Text] [Related]
6. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia). Guglielmetti P, Bianchi Bandinelli ML, Bartoloni A, Gamboa H, Roselli M, Valensin PE. J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946 [Abstract] [Full Text] [Related]
7. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran. Karimi A, Arjomandi A, Alborzi A, Rasouli M, Kadivar MR, Obood B, Pourabbas B. East Mediterr Health J; 2004 Aug; 10(4-5):468-73. PubMed ID: 16335636 [Abstract] [Full Text] [Related]
8. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM. J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246 [Abstract] [Full Text] [Related]
9. [The study of countermeasures on measles control in infants]. Wang L, Sun L, Jiang Z, Kang S, Liu Y, Jiang X. Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb 01; 22(1):49-50. PubMed ID: 11860845 [Abstract] [Full Text] [Related]
10. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study]. Pannuti CS, de Souza VA, Sato HK, Fink MC, Ribeiro MI, Hisi SK, Castelo A, de Mendonça JS. Rev Inst Med Trop Sao Paulo; 1990 Feb 01; 32(6):450-5. PubMed ID: 2135492 [Abstract] [Full Text] [Related]
16. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups. Ogunmekan DA, Harry TO. Trop Geogr Med; 1981 Dec 01; 33(4):379-82. PubMed ID: 7342385 [Abstract] [Full Text] [Related]
20. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related] Page: [Next] [New Search]